Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis including current skin involvement: results of a phase 3, randomized, controlled trial

dc.contributor.author	BLANCO GARCIA, FRANCISCO JAVIER
dc.date.accessioned	2017-06-07T06:56:41Z
dc.date.available	2017-06-07T06:56:41Z
dc.date.issued	2013
dc.identifier.issn	0003-4967
dc.identifier.uri	http://hdl.handle.net/20.500.11940/850
dc.language.iso	eng
dc.title	Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis including current skin involvement: results of a phase 3, randomized, controlled trial
dc.type	Publicación de congreso
dc.authorsophos	Birbara, C.
dc.authorsophos	Blanco, F. J.
dc.authorsophos	Crowley, J. J.
dc.authorsophos	Hu, C.
dc.authorsophos	Stevens, R.
dc.authorsophos	Edwards, C. J.
dc.identifier.isi	331587901307
dc.identifier.sophos	11518
dc.issue.number	supl 3
dc.journal.title	Annals of the rheumatic diseases
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña::INIBIC.- Instituto de Investigación Biomédica
dc.page.initial	85
dc.page.final	86
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	72

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.